Mismatched Priorities Extend Lab Market Woes

Commercial landlords’ business model and small biotech companies’ needs are at odds, throwing obstacles in the paths of filling empty lab buildings and form the next generation of industry giants, alike.

Everyone Wants a Piece of Biotech Startups

As life science tenant space requirements become scarcer in the more conservative venture capital climate, Boston area developers are adapting to the new leasing landscape with incubator space aimed at small startups.

Bulfinch, Partner Buy Piece of MIT Property in $1.1B Deal

Massachusetts Institute of Technology is selling a partial ownership of its 1 Portland St. and 610 and 700 Main St. office and lab buildings to Boston-based Bulfinch Cos. and Harrison Street Capital in a deal valued at $1.1 billion, or $1,626 per square foot.